Emcure Pharmaceuticals Limited (EMCURE) Share Analysis
NSE · Healthcare · Healthcare
Emcure Pharmaceuticals Limited (NSE: EMCURE) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 21 Sep 2026, the share price was ₹2,004.00, market capitalisation ₹38,014 Cr, P/E 36.9, ROE 20.1%.
Get the AI verdict on EMCURE: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
EMCURE price and valuation
- Share price
- ₹2,004.00
- Market cap
- ₹38,014 Cr
- P/E ratio
- 36.9
- P/B ratio
- 7.68
- EPS
- ₹53.34
- Book value per share
- ₹261.00
- Dividend yield
- 0.18%
EMCURE profitability and growth
- ROE
- 20.1%
- ROCE
- 24%
- Debt to equity
- 0.31
- Revenue growth (3 yr)
- 15%
- Revenue growth (5 yr)
- 13%
- Profit growth (3 yr)
- 21%
- Profit growth (5 yr)
- 18%
EMCURE 52-week range
- 52-week high
- ₹2,100.70
- 52-week low
- ₹1,260.00
- Face value
- ₹10.00
EMCURE shareholding pattern
- Promoters
- 77.83%
- FIIs
- 4.87%
- DIIs
- 8.46%
- Public
- 8.84%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.